Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Partnering with Health Systems to Enhance Diverse Patient Access in Trials

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:12192258
archived

Using specific trials as examples, Dr Chetan Karyekar shares how Janssen Immunology is partnering with academic and community health systems to enhance diversity in clinical trials through recruitment strategies, outreach to local institutions, engaging in market research and building trustworthiness.

Speaker:

Chetan Karyekar, MD, PhD, VP, Clinical Development — Rare Diseases & Rheumatology, Janssen

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled